BVF INC

HTTP://WWW.BVFLP.COM • SAN FRANCISCO, CA • Investment Advisor • Hedge Fund
Download 13F Summary
Create Email Alert

Subscription Required

Equal-WT
WhaleScore 2.0 ?

80

S&P 500
WhaleScore ?

Subscription Required

Original
WhaleScore ?

BVF is based out of San Francisco. BVF is a hedge fund with 5 clients and discretionary assets under management (AUM) of $4,498,633,095 (Form ADV from 2023-03-29). Their last reported 13F filing for Q1 2023 included $2,735,588,523 in managed 13F securities and a top 10 holdings concentration of 49.25%. BVF's largest holding is MoonLake Immunotherapeutics with shares held of 21,751,284. BVF has met the qualifications for inclusion in our WhaleScore system. Whalewisdom has at least 90 13F filings

03/31/2023

13F Activity

  • Market Value $2.736 Billion
  • Prior Market Value $2.369 Billion
  • New Purchases4 stocks
  • Additional Purchases18 stocks
  • Sold out of10 stocks
  • Reduced holdings in6 stocks
  • Top 10 Holdings % 49.25 %
  • Turnover % [1]:19.44%
  • Turnover Alt % [2]: 7.40 %
  • Time Held Top20:4.75 quarters
  • Time Held Top10:2.70 quarters
  • Time Held All:10.08 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

03/31/2023

13F Sector Allocation Over Time

Fund Metrics

You are limited to the prior 8 quarters of 13F filings. Subscribe to WhaleWisdom to view all filing data for BVF INC

Portfolio Analysis

Classifications:

Q1 2023:

  • Subscription Required
  • Subscription Required

Consistent Across Past 4 Quarters:

  • Subscription Required
  • Subscription Required
Type of 13F Disclosure 13F Holdings Report
% of holdings ETF 0.0
% of top 20 holdings the same as top 20 most commonly held by all managers 0.0%
ALL HOLDINGS TOP-20 HOLDINGS
min max mean median min max mean median
Market Cap Premium subscription required
Time Held (# of quarters) Premium subscription required
Stock BETA (1-yr) Premium subscription required
Price/Earnings Premium subscription required
Dividend Yield Premium subscription required
Earnings Per Share Premium subscription required
Piotroski Score Premium subscription required
Book Value Per Share Premium subscription required
Price to Book Premium subscription required
Tangible Book Value Per Share Premium subscription required
Rev. Growth Premium subscription required
EPS Growth Premium subscription required
Current Ratio Premium subscription required
Quick Ratio Premium subscription required
Enterprise Value Premium subscription required
Debt to Equity Premium subscription required
Sector Allocation 0.013% (INFORMATION TECHNOLOGY) 78.94% (HEALTH CARE) 20.0% 1.522% 24.071% (FINANCE) 75.929% (HEALTH CARE) 50.0% 50.0%

Risk/Reward Analysis

Portfolio Market Cap Analysis

Portfolio Performance

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-05-15

Performance for Q1 2023: 1.45%
Performance Last 4 Quarters: 30.59%
Performance Metrics
Stdev (5-yrs): Subscription required BETA (5-yrs): Subscription required ALPHA (3-yrs): Subscription required
Max Drawdown (all-years): Subscription required Annualized Perf (3-yrs): Subscription required Batting Avg vs S&P. (3-yrs): Subscription required
Sortino (3-yrs): Subscription required Stutzer (3-yrs): Subscription required Treynor (3-yrs): Subscription required
Sterling (3-yrs): Subscription required Calmar (3-yrs): Subscription required Information Ratio (3-yrs): Subscription required
Tracking Error (3 yrs): Subscription required Stdev Down (3-yrs): Subscription required Winning Months %: Subscription required
Losing Months %: Subscription required Best 12 Months: Subscription required Worst 12 Months: Subscription required
Efficiency Ratio (3-yrs): Subscription required Sharpe: Subscription required Stdev Sectors: Subscription required
Skewness (3-yrs): Subscription required Kurtosis (3-yrs): Subscription required Upside Potential (3-yrs): Subscription required
Refresh Advanced Export Download CSV Download Excel (.xlsx) Download TSV
Filter by:

Click to See Additional Filters

Security Types:

Refresh
*Shares are split adjusted
This lets you look at individual sub managers or subsidiaries within the 13F filing.

13F Managers

Subsidiaries/Managers included in latest 13F
Name
BVF PARTNERS L P/IL

View Last Form Adv Compilation Report on Record

BVF PARTNERS L.P.
Classified as Hedge Fund
44 MONTGOMERY STREET SUITE 4000
SAN FRANCISCO CA    94104
Country: United States
Business Phone: 415-525-8800
Fax: 415-525-8801
Professional Investment Advisor Data
SEC Registration as : Large Advisory Firm
Form of Organization: Limited Partnership
Organized in: DE
Number of employees: 12
Other Business Activities:
Advisor Fees/Compensation: Percentage of assets under management,Performance-based fees
Amount of client funds and securities: 10,119,100
Total Number of Clients: 5
Amount of client funds and securities by related persons: 4,418,110,000
Total Number of clients from related persons: 4
Disclosures: 11.D (2)
Data above was derived from SEC filings.

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

BVF PARTNERS L.P.

ownership team - last updated 2023-03-29
Name Title Start Date Direct/Indirect % Ownership
LAMPERT, MARK, NATHAN CHIEF EXECUTIVE OFFICER 11/01/1993 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01
MCCUNE, JASON, ROBERT CHIEF OPERATING OFFICER 07/01/2019 Direct less than 5%
Fund Name Position direct/indirect start date end date
HALL CAPITAL PARTNERS LLC ABSOLUTE RETURN/CREDIT RESEARCH, MEMBER CLASS C, MANAGING DIRECTOR direct 2018-01-01
KRATKY, JAMES, GEOFFREY CHIEF FINANCIAL OFFICER, CHIEF COMPLIANCE OFFICER 05/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER direct 2017-05-01
PERRY, MATTHEW PRESIDENT 03/01/2014 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. PRESIDENT direct 2014-03-01
BVF INC. GENERAL PARTNER 11/01/1993 Direct 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. GENERAL PARTNER direct 1993-11-01
LAMPERT, MARK, NATHAN SHAREHOLDER BVF INC. 08/01/1993 Indirect 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
BIOTECHNOLOGY VALUE FUND II, L.P. United States 805-6974108223 Hedge Fund 1,817,159,232 25,000,000
BVF INVESTMENTS, LLC United States 805-5087068635 Hedge Fund 684,236 25,000,000
BIOTECHNOLOGY VALUE TRADING FUND OS LP Cayman Islands 805-7732417225 Hedge Fund 218,173,311 2,500,000 Master Fund
BIOTECHNOLOGY VALUE FUND, LP United States 805-6980425183 Hedge Fund 2,382,781,182 25,000,000

BVF PARTNERS L.P.

ownership team - last updated 2022-03-31
Name Title Start Date Direct/Indirect % Ownership
LAMPERT, MARK, NATHAN CHIEF EXECUTIVE OFFICER 11/01/1993 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01
MCCUNE, JASON, ROBERT CHIEF OPERATING OFFICER 07/01/2019 Direct less than 5%
Fund Name Position direct/indirect start date end date
HALL CAPITAL PARTNERS LLC ABSOLUTE RETURN/CREDIT RESEARCH, MEMBER CLASS C, MANAGING DIRECTOR direct 2018-01-01
KRATKY, JAMES, GEOFFREY CHIEF FINANCIAL OFFICER, CHIEF COMPLIANCE OFFICER 05/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER direct 2017-05-01
PERRY, MATTHEW PRESIDENT 03/01/2014 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. PRESIDENT direct 2014-03-01
BVF INC. GENERAL PARTNER 11/01/1993 Direct 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. GENERAL PARTNER direct 1993-11-01
LAMPERT, MARK, NATHAN SHAREHOLDER BVF INC. 08/01/1993 Indirect 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
BIOTECHNOLOGY VALUE FUND II, L.P. United States 805-6974108223 Hedge Fund 1,990,560,662 25,000,000
BVF INVESTMENTS, LLC United States 805-5087068635 Hedge Fund 1,543,207 25,000,000
BIOTECHNOLOGY VALUE TRADING FUND OS LP Cayman Islands 805-7732417225 Hedge Fund 278,742,780 2,500,000 Master Fund
BIOTECHNOLOGY VALUE FUND, LP United States 805-6980425183 Hedge Fund 2,543,278,010 25,000,000

BVF PARTNERS L.P.

ownership team - last updated 2021-03-30
Name Title Start Date Direct/Indirect % Ownership
LAMPERT, MARK, NATHAN CHIEF EXECUTIVE OFFICER 11/01/1993 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01
MCCUNE, JASON, ROBERT CHIEF OPERATING OFFICER 07/01/2019 Direct less than 5%
Fund Name Position direct/indirect start date end date
HALL CAPITAL PARTNERS LLC ABSOLUTE RETURN/CREDIT RESEARCH, MEMBER CLASS C, MANAGING DIRECTOR direct 2018-01-01
KRATKY, JAMES, GEOFFREY CHIEF FINANCIAL OFFICER, CHIEF COMPLIANCE OFFICER 05/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER direct 2017-05-01
PERRY, MATTHEW PRESIDENT 03/01/2014 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. PRESIDENT direct 2014-03-01
BVF INC. GENERAL PARTNER 11/01/1993 Direct 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. GENERAL PARTNER direct 1993-11-01
LAMPERT, MARK, NATHAN SHAREHOLDER BVF INC. 08/01/1993 Indirect 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
BIOTECHNOLOGY VALUE FUND II, L.P. United States 805-6974108223 Hedge Fund 1,778,619,322 25,000,000
BVF INVESTMENTS, LLC United States 805-5087068635 Hedge Fund 1,831,137 25,000,000
BIOTECHNOLOGY VALUE TRADING FUND OS LP Cayman Islands 805-7732417225 Hedge Fund 306,522,432 2,500,000 Master Fund
BIOTECHNOLOGY VALUE FUND, LP United States 805-6980425183 Hedge Fund 2,472,898,462 25,000,000

BVF PARTNERS L.P.

ownership team - last updated 2020-03-30
Name Title Start Date Direct/Indirect % Ownership

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
BIOTECHNOLOGY VALUE FUND II, L.P. United States 805-6974108223 Hedge Fund 946,863,194 25,000,000
BVF INVESTMENTS, LLC United States 805-5087068635 Hedge Fund 4,454,441 25,000,000
BIOTECHNOLOGY VALUE TRADING FUND OS LP Cayman Islands 805-7732417225 Hedge Fund 163,036,031 2,500,000 Master Fund
BIOTECHNOLOGY VALUE FUND, LP United States 805-6980425183 Hedge Fund 1,172,959,958 25,000,000

BVF PARTNERS L.P.

ownership team - last updated 2019-09-30
Name Title Start Date Direct/Indirect % Ownership
LAMPERT, MARK, NATHAN CHIEF EXECUTIVE OFFICER 11/01/1993 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01
MCCUNE, JASON, ROBERT CHIEF OPERATING OFFICER 07/01/2019 Direct less than 5%
Fund Name Position direct/indirect start date end date
HALL CAPITAL PARTNERS LLC ABSOLUTE RETURN/CREDIT RESEARCH, MEMBER CLASS C, MANAGING DIRECTOR direct 2018-01-01
KRATKY, JAMES, GEOFFREY CHIEF COMPLIANCE OFFICER 05/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER direct 2017-05-01
PERRY, MATTHEW PRESIDENT 03/01/2014 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. PRESIDENT direct 2014-03-01
BVF INC. GENERAL PARTNER 11/01/1993 Direct 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. GENERAL PARTNER direct 1993-11-01
LAMPERT, MARK, NATHAN SHAREHOLDER BVF INC. 08/01/1993 Indirect 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
BIOTECHNOLOGY VALUE FUND II, L.P. United States 805-6974108223 Hedge Fund 511,605,899 25,000,000
BVF INVESTMENTS, LLC United States 805-5087068635 Hedge Fund 4,454,441 25,000,000
BIOTECHNOLOGY VALUE TRADING FUND OS LP Cayman Islands 805-7732417225 Hedge Fund 85,995,580 2,500,000 Master Fund
BIOTECHNOLOGY VALUE FUND, LP United States 805-6980425183 Hedge Fund 658,959,916 25,000,000

BVF PARTNERS L.P.

ownership team - last updated 2019-03-28
Name Title Start Date Direct/Indirect % Ownership
LAMPERT, MARK, NATHAN CHIEF EXECUTIVE OFFICER 11/01/1993 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01
KAYE, MITCHELL, D CHIEF OPERATING OFFICER 01/01/2016 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER; CHIEF OPERATING OFFICER direct 2016-01-01
BVF PARTNERS L.P. CHIEF OPERATING OFFICER direct 2016-01-01
KRATKY, JAMES, GEOFFREY CHIEF COMPLIANCE OFFICER 05/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER direct 2017-05-01
PERRY, MATTHEW PRESIDENT 03/01/2014 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. PRESIDENT direct 2014-03-01
BVF INC. GENERAL PARTNER 11/01/1993 Direct 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. GENERAL PARTNER direct 1993-11-01
LAMPERT, MARK, NATHAN SHAREHOLDER BVF INC. 08/01/1993 Indirect 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
BVF INVESTMENTS, LLC United States 805-5087068635 Hedge Fund 4,454,441 25,000,000
BIOTECHNOLOGY VALUE TRADING FUND OS LP Cayman Islands 805-7732417225 Hedge Fund 85,995,580 2,500,000 Master Fund
BIOTECHNOLOGY VALUE FUND, LP United States 805-6980425183 Hedge Fund 658,959,916 25,000,000
BIOTECHNOLOGY VALUE FUND II, L.P. United States 805-6974108223 Hedge Fund 511,605,899 25,000,000

BVF PARTNERS L.P.

ownership team - last updated 2017-05-04
Name Title Start Date Direct/Indirect % Ownership
LAMPERT, MARK, NATHAN CHIEF EXECUTIVE OFFICER 11/01/1993 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01
KAYE, MITCHELL, D CHIEF OPERATING OFFICER 01/01/2016 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER; CHIEF OPERATING OFFICER direct 2016-01-01
BVF PARTNERS L.P. CHIEF OPERATING OFFICER direct 2016-01-01
KRATKY, JAMES, GEOFFREY CHIEF COMPLIANCE OFFICER 05/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. CHIEF COMPLIANCE OFFICER direct 2017-05-01
PERRY, MATTHEW PRESIDENT 03/01/2014 Direct less than 5%
Fund Name Position direct/indirect start date end date
BVF PARTNERS L.P. PRESIDENT direct 2014-03-01
BVF INC. GENERAL PARTNER 11/01/1993 Direct 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. GENERAL PARTNER direct 1993-11-01
LAMPERT, MARK, NATHAN SHAREHOLDER BVF INC. 08/01/1993 Indirect 75% or more
Fund Name Position direct/indirect start date end date
BVF PARTNERS, L.P. SHAREHOLDER indirect 1993-08-01
BVF PARTNERS L.P. CHIEF EXECUTIVE OFFICER direct 1993-11-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
BVF INVESTMENTS, LLC United States 805-5087068635 Hedge Fund 38,581,354 25,000,000
BIOTECHNOLOGY VALUE TRADING FUND OS LP Cayman Islands 805-7732417225 Hedge Fund 74,763,781 2,500,000 Master Fund
BIOTECHNOLOGY VALUE FUND, LP United States 805-6980425183 Hedge Fund 514,581,181 2,500,000
BIOTECHNOLOGY VALUE FUND II, L.P. United States 805-6974108223 Hedge Fund 325,485,637 2,500,000

WhaleScore history for BVF INC

You must have a subscription to view WhaleScore histories

Elevate your investments